| __timestamp | Johnson & Johnson | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 8494000000 | 14182353 |
| Thursday, January 1, 2015 | 9046000000 | 15503028 |
| Friday, January 1, 2016 | 9095000000 | 16183585 |
| Sunday, January 1, 2017 | 10554000000 | 22382849 |
| Monday, January 1, 2018 | 10775000000 | 33038206 |
| Tuesday, January 1, 2019 | 11355000000 | 31777040 |
| Wednesday, January 1, 2020 | 12340000000 | 41464134 |
| Friday, January 1, 2021 | 14277000000 | 67178053 |
| Saturday, January 1, 2022 | 14135000000 | 52531000 |
| Sunday, January 1, 2023 | 15048000000 | 68914000 |
| Monday, January 1, 2024 | 17232000000 |
Cracking the code
In the ever-evolving pharmaceutical landscape, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Johnson & Johnson and Pharming Group N.V. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Johnson & Johnson consistently increased its R&D expenses, culminating in a 77% rise, reaching approximately $15 billion in 2023. This robust investment underscores their dedication to pioneering healthcare solutions.
Conversely, Pharming Group N.V., while significantly smaller, has shown a remarkable 386% increase in R&D spending over the same period, albeit from a much lower base. This growth reflects their strategic focus on niche markets and innovative therapies. The stark difference in scale and growth rates between these two companies highlights the diverse strategies within the pharmaceutical industry, where both giants and niche players strive to make impactful advancements.
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Research and Development Investment: Johnson & Johnson vs Pfizer Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Zoetis Inc.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Research and Development Investment: Pharming Group N.V. vs Amicus Therapeutics, Inc.
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and MorphoSys AG
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
Analyzing R&D Budgets: Pharming Group N.V. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Taro Pharmaceutical Industries Ltd.